Zhejiang Xianju Pharmaceutical Co.,Ltd. (China)

Zhejiang Xianju Pharmaceutical Co., Ltd. was establishedin 1972. Currently, there are 1,795 employees, among whom30% are technicians, and 36% are sales. It is a manufactureof APl and drug products.It mainly produces corticoid and sex hormones(progesterone, estrogen and androgen). At present, there aremore than 100 varieties. It has a production capacity of 200tons APl, 7 billion tablets, 500 million capsules, 200million aqua injections, 10 million lyophilized powderinjections, 10 million creams, and 10 million packets ofgranules.The company has established long-term cooperation relationwith more than 20 famous domestic and internationalscientific research institutes. In recent years, it hassuccessfully developed more than 20 kinds of high-techdrugs, and achieved almost 10 scientific research results,among which 8 products are breakthroughs. ZXH951, a newanti-early pregnancy class 1 drug, is listed into theNational 863 plan. Hanzhuting (Mifepristone tablet), ananti-early pregnancy drug and Xianlin (Vecuronium Bromidefor injection), a kind of muscle relaxant are both ZhejiangFamous Brand Products. Vecuronium Bromide was approved byU.S. FDA. Prednisolone was granted COS and South Korea KFDAcertificate. All products have passed by SFDA according toChina GMRIn the next five years, based on comparative advantage,Xianju Pharma will strive for continuous innovation, improveinvesting bodies and structure, and expand production andoperation scale, hence to form a large-scale medicine groupenterprise which integrates medicine production, sales andmedical treatment service.